At Chipiron,
we are on a mission to end cancer
through scalable MRI technologies.

Most deadly diseases can be efficiently cured through early diagnosis and image-guided non-invasive therapies using today’s MRI technology.

To implement widespread screening and advanced therapies, MRI accessibility needs to increase by 100-fold.

With its outrageous costs, prohibitively complex infrastructure, and extensive MR compatibility issues, current MRI technology will never be able to meet the demand.

Introducing Chipiron

Leveraging the emerging properties of ultra-low magnetic fields (<10 mT), we are building the first light, inexpensive, open full-body MRI machine without compromising image quality.

NO SHIELDED ROOM NEEDED
ONE-PERSON MOVABLE
WORKS FROM STANDARD OUTLET
non-technician operable
01
02
03
04

TECHNOLOGY

We have built the most advanced MRI technology stack ever

01
02
03
04
01

QUANTUM SQUID DETECTION SYSTEM

Our patented low-Tc SQUID volume gradiometer is the world’s first SQUID antenna capable of acquiring an MRI signal in an open environment, improving the SNR up to 10x compared to previous attempts.

02

STATE OF THE ART AI NOISE CANCELLATION SYSTEM

We implement cutting-edge linear and non-linear active noise cancellation strategies to make the most out of the lower signals.

03

ULTRA-LIGHT COOLING SYSTEM

We designed and built the first MRI-compatible SQUID cryostat, which allows the detector to stay at 4 K while gathering the NMR signal as efficiently as a room-temperature coil.

04

UNCONVENTIONNAL LOW-FIELD AI RECONSTRUCTION

Ultra-low field EPI, partial Fourier, and Gaussian undersampling with unconventional reconstruction are the last bricks to reduce the number of repetitions to pack ULF sequences in clinically relevant acquisition times.

ROADMAP

We're on the way to our commercial launch in 3 years

AUGUST, 2024

Beginning prototyping our investigational device

NOVEMBER, 2025

End of phase 2 of R&D: clinical-grade image quality

APRIL, 2026

Opening of US offices in Boston, MA
Pre-submission FDA

SEPTEMBER, 2026

FDA Submission

Apr, 2027

FDA 510(k) clearance

Latest news


Chipiron has been selected to receive up to 2.5M€ in grants and 15M€ in equity investment from the prestigious EIC Accelerator.


Chipiron has been awareded an 3.6M€ non-dilutive investment by France 2030 as an Innovator in Medical Imaging.


Chipiron has been awarded « Medtech of the Year » by the prestigious association France Biotech.


Release of Chipiron White Paper v3 including our first images produced in Q4 2023.


Chipiron founders have been awarded « Innovator of the Year » from the famous French Magazine Le Point.


Read about us in Le Monde, the most renowned French newspaper.

Careers

Don’t see a position that strikes your fancy?

We are always looking for exceptional talents. Go ahead and send us an application at join@chipiron.co

Product Manager

— The Ark, Hybrid

Head of MRI Product Development and Clinical Strategy

— The Ark, Hybrid

Director of Clinical Validation

— The Ark, Hybrid

RF Analog Engineer

— The Ark, Hybrid

Electronic Engineer

— The Ark, Hybrid

Integration Testing Engineer (Hardware)

— The Ark, Hybrid

Internship – Fabrication of human scale RF coils for 1mT SQUID MRI

— The Ark, Hybrid

Internship – Modelling and characterisation of physiological constraints for low field MRI

— The Ark, Hybrid